September 27, 2021

Now available ILARIS®

ILARIS® (canakinumab) injection, for subcutaneous use, is indicated to treat certain types of periodic fever syndromes, which include cryopyrin-associated periodic syndromes (CAPS), tumor necrosis factor receptor associated periodic syndrome (TRAPS), hyperimmunoglobulin D syndrome (HIDS)/mevalonate kinase deficiency (MKD), and familial Mediterranean fever (FMF).

View full prescribing information.